Effect of Long-Term Metformin and Lifestyle in the Diabetes Prevention Program and Its Outcome Study on Coronary Artery Calcium
Author(s) -
Ronald Goldberg,
Vanita R. Aroda,
David A. Bluemke,
Elizabeth BarrettConnor,
Matthew J. Budoff,
Jill P. Crandall,
Dana Dabelea,
Edward S. Horton,
Kieren J. Mather,
Trevor J. Orchard,
David S. Schade,
Karol E. Watson,
Marinella Temprosa
Publication year - 2017
Publication title -
circulation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 7.795
H-Index - 607
eISSN - 1524-4539
pISSN - 0009-7322
DOI - 10.1161/circulationaha.116.025483
Subject(s) - medicine , metformin , coronary artery calcium , diabetes mellitus , calcium , term (time) , cardiology , coronary artery disease , endocrinology , physics , quantum mechanics
Despite the reduced incidence of coronary heart disease with intensive risk factor management, people with diabetes mellitus and prediabetes remain at increased coronary heart disease risk. Diabetes prevention interventions may be needed to reduce coronary heart disease risk. This approach was examined in the DPP (Diabetes Prevention Program) and the DPPOS (Diabetes Prevention Program Outcome Study), a long-term intervention study in 3234 subjects with prediabetes (mean±SD age, 64±10 years) that showed reduced diabetes risk with lifestyle and metformin compared with placebo over 3.2 years.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom